Agreed. Todays q figures not too bad either. Seems a goodlaughtoday might have been missing something after all....;)
Well if you look at year in total, and that Q3 2011 was lower than Q3 2010 i.e. only 10% increase over two years and half that growth is royalties………
Total revenue for the nine-month period ended September 30, 2012 was $159.5 million, a decrease of $1.6 million or 1% compared to $161.1 million for the same period in 2011.
And how is the purchase of Hyaluron in Mass doing????? Still no FDA approval after two years
Contract revenue for Development/Small-Scale Manufacturing in the nine-month period ended September 30, 2012 was $25.2 million, a decrease of 12% from $28.7 million in 2011.